糖尿病前期及糖尿病患者膳食n-3脂肪酸摄入量与全因及心血管死亡的关系
研究纳入2003至2018年美国国家健康与营养调查(NHANES)中16539例糖尿病前期或糖尿病患者,按n-3多不饱和脂肪酸(PUFA)摄入量三分位分组,中位随访8.42年。多变量校正后,T2组全因死亡风险为0.81(0.71-0.92),T3组为0.77(0.64-0.94),T2组心血管死亡风险为0.75(0.61-0.93),均低于参照组T1。限制性立方样条显示负向非线性关联,加权分位数和模型提示α-亚麻酸(ALA)和二十二碳五烯酸(DPA)是主要贡献成分。
要点
- 糖尿病前期及糖尿病患者中,膳食n-3 PUFA摄入量较高与全因及心血管死亡风险降低相关。
- 多变量校正后,T2组全因死亡风险0.81(0.71-0.92),T3组0.77(0.64-0.94),均低于T1组。
- T2组心血管死亡风险0.75(0.61-0.93),低于T1组;亚组分析除BMI外交互作用均无统计学意义。
核心结论
- 增加膳食n-3 PUFA摄入,尤其是ALA和DPA,与糖尿病前期及糖尿病患者全因和心血管死亡风险降低相关。
研究设计与样本
- 研究纳入2003至2018年美国国家健康与营养调查(NHANES)中16539例糖尿病前期或糖尿病患者,按n-3 PUFA摄入量三分位分为T1、T2、T3组。
- 采用Cox比例风险回归模型、Kaplan-Meier曲线和亚组分析评估n-3 PUFA与死亡的关系,用限制性立方样条(RCS)曲线展示剂量反应关系,用加权分位数和(WQS)模型衡量混合及单独效应。
主要发现
- 中位随访8.42年期间,共3010例死亡,其中989例归因于心血管疾病。
- 多变量校正后,与参照组T1相比,T2组全因死亡风险为0.81(0.71-0.92),T3组为0.77(0.64-0.94);T2组心血管死亡风险为0.75(0.61-0.93)。
- RCS曲线显示n-3 PUFA与死亡率之间呈负向非线性关联。
- 亚组分析中,除BMI外(交互作用P=0.049),其余交互作用均无统计学意义。
- WQS分析显示ALA和DPA是n-3 PUFA降低死亡风险的主要贡献成分。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CONTEXT: While the association between n-3 polyunsaturated fatty acids (PUFAs) and cardiovascular (CV) events has been thoroughly examined, there is still a scarcity of research regarding their effect on the long-term prognosis in diabetic patients. OBJECTIVE: We aimed to explore the effects of n-3 PUFA on all-cause and cardiovascular mortality in patients with pre-diabetes and diabetes. METHOD: Herein, a total of 16 539 eligible individuals were enrolled from the National Health and Nutrition Examination Survey (NHANES) 2003 to 2018, and categorized into T1, T2, and T3 based on the tertiles of n-3 PUFA. The Cox proportional risk regression models, Kaplan-Meier curve, and subgroup analysis were conducted to evaluate the association between n-3 PUFA and mortality. Restricted cubic spline (RCS) curves graphically demonstrated the dose-response relationship. Additionally, weighted quantile sum (WQS) models were adopted to measure the mixed and individual effects of n-3 PUFA on mortality. RESULTS: Following a median follow-up period of 8.42 years, 3010 individuals died, with 989 deaths attributed to CV diseases. Significantly lower risk of all-cause (T2: 0.81 [0.71-0.92], T3: 0.77 [0.64-0.94]) and CV (T2: 0.75 [0.61-0.93]) mortality was observed after adjusting for multivariables compared to the reference (T1). Meanwhile, the RCS curve revealed a negative nonlinear association between n-3 PUFA and mortality. None of the interactions in any subgroup analysis were statistically significant except for BMI (P for interaction = .049). Finally, the WQS analysis demonstrated alpha-linolenic acid (ALA) and docosapentaenoic acid (DPA) as the main contributors to n-3 PUFAs' benefits against mortality. CONCLUSION: Increased dietary intake of n-3 PUFAs, particularly ALA and DPA, was associated with a reduced risk of all-cause and CV mortality among Americans with prediabetes and diabetes.
引用
- Che J, He N, Kuang X, et al. Dietary n-3 Fatty Acids Intake and All-Cause and Cardiovascular Mortality in Patients With Prediabetes and Diabetes. J Clin Endocrinol Metab. 2024. PMID: 38625900. doi:10.1210/clinem/dgae265
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。